Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)
Launched by UNIVERSITY OF WASHINGTON · Feb 11, 2011
Trial Information
Current as of August 19, 2025
Completed
Keywords
ClinConnect Summary
The investigators propose a longitudinal study of 500 women in order to determine rates and risk factors for HPV infections in 30-50 year old women. Participants will be followed for 6 months and will be asked to complete online questionnaires on their health, sexual behavior, HPV vaccinations, and cervical cancer screening. The investigators will ask participants to self-collect monthly vaginal swab samples and self-collect 2 oral swab samples. Women will also be asked to provide 2 blood samples. All swab samples will be tested for type-specific HPV deoxyribonucleic acid (DNA) using a poly...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • affiliated with the University of Washington (student, staff, faculty)
- • willing to self-collect vaginal samples at home for HPV testing
- • able to provide informed consent
- Exclusion Criteria:
- • pregnant
- • have had hysterectomy
- • serious medical condition which prevents completion of activities of daily living
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Rachel L Winer, PhD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials